Skip to main content

Month: February 2021

Bitfarms Announces Closing of CAD$40.0 Million Private Placement with U.S. Institutional Investors

TORONTO and BROSSARD, Québec, Feb. 10, 2021 (GLOBE NEWSWIRE) — Bitfarms Ltd. (“Bitfarms”, or the “Company”) (TSXV:BITF) (U.S.:OTC:BFARF), one of the largest and most productive publicly listed bitcoin mining operations in the world, is pleased to announce that it has closed its previously announced private placement of equity securities (the “Offering”). The Offering was for gross proceeds of approximately CAD$40 million and consisted of the sale of 11,560,695 common shares, along with warrants to purchase an aggregate of up to 11,560,695 common shares, at a purchase price of CAD$3.46 per common share and associated warrant. The warrants have an exercise price of USD$3.01 per common share and exercise period of three and one-half years (through August 12, 2024). The funds were raised via a fully subscribed private placement of units...

Continue reading

Prestige Consumer Healthcare Inc. Announces Upsize and Pricing of $600 Million Senior Notes

TARRYTOWN, N.Y., Feb. 10, 2021 (GLOBE NEWSWIRE) — Prestige Consumer Healthcare Inc. (NYSE: PBH) (the “Company”) announced today that its wholly-owned subsidiary, Prestige Brands, Inc. (“Prestige Brands”), has priced an upsized offering of $600 million in aggregate principal amount of 3.750% senior notes due 2031 (the “notes”) in a private offering. The sale of the notes is expected to be completed on or about March 1, 2021, subject to customary closing conditions. The notes will be senior unsecured obligations of Prestige Brands and will be guaranteed by the Company and certain of its domestic subsidiaries.The Company intends to use the net proceeds from the offering, together with cash on hand, to redeem all $600 million of Prestige Brands’ outstanding 6.375% Senior Notes due 2024, and to pay related fees and expenses.The notes...

Continue reading

Delta 9 Provides Guidance & Timing for Year End 2020 Results

WINNIPEG, Manitoba, Feb. 10, 2021 (GLOBE NEWSWIRE) — DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: VRNDF) (“Delta 9” or the “Company”), is pleased to provide guidance on select fourth quarter and year end results ending December 31, 2020 based on preliminary results:The Company anticipates net revenues for the three-month period ending December 31, 2020 to be between $13.7 million and $14.2 million. This compares with:$10.6 million for the same period in 2019, an increase of between 29% and 34%.$13.1 million sequentially from the third quarter of 2020, an increase of between 5% and 8%The Company anticipates revenues for the year ending December 31, 2020 to be between $51.8 million and $52.3 million, compared to $31.8 million for the same period in the prior year.The Company anticipates reporting direct cannabis...

Continue reading

Pilgrim’s Names Matthew Galvanoni Chief Financial Officer

GREELEY, Colo., Feb. 10, 2021 (GLOBE NEWSWIRE) — Pilgrim’s Pride Corporation (NASDAQ: PPC) announced today that Matthew Galvanoni, an executive with more than 26 years of finance and accounting experience with publicly-traded companies, has joined Pilgrim’s as global chief financial officer, effective March 15. He will report to Pilgrim’s president and global chief executive officer Fabio Sandri.Galvanoni served as vice president, finance at Ingredion Incorporated since 2016, managing all financial-related responsibilities for the $4 billion North American division of the Fortune 500 global manufacturing company. He joined Ingredion in 2012, serving in the role of global corporate controller and chief accounting officer, where he managed the company’s accounting-related and external financial reporting responsibilities.“We are excited...

Continue reading

OliX Pharmaceuticals Announces Results from Preclinical Study of Hair Loss Therapeutic Candidate

Company to discuss study results and present corporate overview at SMi’s 12th Annual RNA Therapeutics Virtual Conference on February 11SUWON, Republic of Korea, Feb. 10, 2021 (GLOBE NEWSWIRE) — OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, announced that it has demonstrated efficacy in a preclinical study of OLX104C, an investigational RNAi therapeutic in development for androgenic alopecia, also known as hair loss.In the study, OLX104C was administered topically to a mouse model with suppressed hair growth (Dihydrotestosterone, DHT administered mouse). The study evaluated the percentage of hair regrowth and duration of knockdown of the target protein, AR, following a single injection. Mice receiving OLX104C showed substantial hair regrowth compared to the control group, and results showed...

Continue reading

COMPAGNIE LEBON : capital et droits de vote janvier 2021

 Middle Office EmetteurTél. : 01 53 48 80 10 – Fax : 01 49 74 32 77 – 34318@cic.frCOMPAGNIE LEBONDate d’arrêté:31/01/2021ARTICLE 223-16 du règlement général de l’AMFActions du capital1 173 000Droits de vote théoriques (1)2 159 017Actions privées de droits de voteAutodétention au nominatif (2)31 380Autodétention au porteur * (3)0Autres * (4)0* à compléter par la sociétéDroits de vote exerçables*2 127 637*= (1) – [(2) + (3) + (4)]Pour information :Nombre de Comptes Courants Nominatifs2 265Pièce jointeDDV Compagnie Lebon 31 01 2021

Continue reading

UPS Announces Quarterly Dividend

ATLANTA, Feb. 10, 2021 (GLOBE NEWSWIRE) — UPS (NYSE: UPS) today announced its regular quarterly dividend of $1.02 per share on all outstanding Class A and Class B shares.The dividend is payable March 10, 2021 to shareowners of record on February 22, 2021. Commitment to the dividend is one of UPS’s core principles and a hallmark of the company’s financial strength. UPS has either maintained or increased its dividend each year since going public in 1999.About UPSUPS (NYSE: UPS) is one of the world’s largest package delivery companies with 2020 revenue of $84.6 billion, and provides a broad range of integrated logistics solutions for customers in more than 220 countries and territories. The company’s more than 540,000 employees embrace a strategy that is simply stated and powerfully executed: Customer First. People Led. Innovation...

Continue reading

Brookfield Infrastructure Announces Intention to Acquire Inter Pipeline Ltd. for C$16.50 per Share in a Transaction Valued at C$13.5 Billion

Highly certain and credible offer delivering immediate 23% premium to Inter Pipeline shareholders Brookfield Infrastructure willing to consider increasing its offer if granted access to due diligenceBrookfield Infrastructure reports an aggregate economic interest in 19.6% of the issued and outstanding shares of IPL, making Brookfield Infrastructure IPL’s single largest investorBROOKFIELD, NEWS, Feb. 10, 2021 (GLOBE NEWSWIRE) — Brookfield Infrastructure Partners L.P. (NYSE: BIP; TSX: BIP.UN), together with its institutional partners (collectively, “Brookfield Infrastructure”), announces today its intention to pursue a privatization transaction in respect of Inter Pipeline Ltd. (“IPL” or the “Company”), pursuant to which it will offer to acquire all of the outstanding common shares of the Company (“IPL Shares”) not already owned by...

Continue reading

Endeavour Completes Teranga Acquisition to Create New Senior Gold Producer

ENDEAVOUR COMPLETES TERANGA ACQUISITIONTO CREATE NEW SENIOR GOLD PRODUCERGeorge Town, February 10, 2021 – Endeavour Mining (“Endeavour” or the “Company”) (TSX: EDV) (OTCQX: EDVMF) is pleased to announce the successful completion of the acquisition of Teranga Gold Corporation (“Teranga”) (TSX: TGZ) (OTCQX:TGCDF) to create a new top 10 global gold producer.Sebastien de Montessus, President and CEO said: “We are delighted to successfully complete our acquisition of Teranga and would like to welcome the teams at the Sabodala-Massawa and Wahgnion mines to our organization. We look forward to quickly integrating our new assets into our West African operating platform and delivering on the anticipated material synergies.Following our recent transformative acquisitions, we are now entering a new chapter of the Company’s history. Leveraging...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.